IVAC and partners launch statement to raise awareness about single-dose HPV vaccination
May 2023
In December 2022, the World Health Organization endorsed a single-dose schedule for HPV vaccination for the primary target age group (9-14 years-old). Since then, additional data continue to build the evidence base in support of its use. As global leaders gather at the World Health Assembly to assess progress and chart priorities, IVAC has joined […]
Read More >